HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

4th Edition of International Heart Congress

June 22-24,2026 | Hybrid Event

June 22 -24, 2026 | Barcelona, Spain

Dyslipidemia

Dyslipidemia

Dyslipidemia is a medical condition characterized by abnormal levels of lipids, including cholesterol and triglycerides, in the blood. It plays a crucial role in the development of cardiovascular diseases, such as atherosclerosis and coronary artery disease. The condition arises when there is an imbalance in the production, utilization, or clearance of lipids, leading to elevated levels of LDL cholesterol, commonly referred to as "bad" cholesterol, and reduced levels of HDL cholesterol, known as "good" cholesterol. Dyslipidemia often results from a combination of genetic factors, lifestyle choices, and underlying health conditions. Poor dietary habits, lack of physical activity, and obesity contribute significantly to its onset. Timely detection and management of dyslipidemia are essential to reduce the risk of cardiovascular events. Lifestyle modifications, including a heart-healthy diet, regular exercise, and smoking cessation, are key components of managing dyslipidemia. In some cases, medications such as statins may be prescribed to help control lipid levels and mitigate cardiovascular risks. Regular monitoring and collaboration with healthcare professionals are crucial for individuals with dyslipidemia to effectively manage and maintain optimal lipid levels, promoting heart health and overall well-being.

Submit your abstract Today

Watsapp